MedTrace Logo

Efficacy of Hydrotherapy on Balance in Neuropathic Patients Post-Burn

NCT06862635 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-07-08

No results posted yet for this study

Summary

Balance problems are common among neuropathic patients following burns, primarily due to sensory and motor impairments.The goal of the study is to investigate the effect of a hydrotherapy program on balance in neuropathic patients following burns. It is a randomized controlled study will be conducted on fifty male patients (age range from 35 to 45 years) with polyneuropathy following lower limb burn injuries, mainly at the sole of the foot, with 3rd-degree injuries and 30% burn extent.

Balance will be assessed before and after treatment using the Biodex Balance System and the Berg Balance Scale (BBS).

Patients will be randomly assigned into two equal groups:

Group A (study group) will receive hydrotherapy sessions including stretching, resistance, and balance exercises in water.

Group B (control group) will receive traditional land-based balance exercises only.

Conditions

Interventions

OTHER

Hydrotherapy

Patients will receive hydrotherapy sessions including stretching, resistance, and balance exercises in water

OTHER

traditional land-based balance exercises

Patients will receive traditional land-based balance exercises in the form of stretching, strengthening and balance exercises.

Sponsors & Collaborators

  • MTI University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-05
Primary Completion
2025-08-05
Completion
2025-08-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06862635 on ClinicalTrials.gov